A Food and Drug Administration (FDA) advisory panel voted 18-0 to authorize a Pfizer booster shot for Americans 65 years and older and those at risk of severe COVID-19 infection.
FDA panel endorses boosters for some 'high-risk' Americans
Credit: ABC 10 News | San Diego
Duration: 01:52s
0 shares
3 views